MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer

Background and purposeLocally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a cohort enrolled across two institutions investigating MRI-guided tumor-targeted salvage high dose rate brachytherapy (HDR...

Full description

Bibliographic Details
Main Authors: Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu (Amy) Liu, Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas, Samuel Kadoury, Alexandra Rink, Srinivas Raman, Aravindhan Sundaramurthy, Robert Weersink, Dominic Beliveau-Nadeau, Joelle Helou, Peter Chung
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
brachytherapy
salvage
radiotherapy
magnetic resonance imaging
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.971344/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.971344/full

Similar Items